iBio
IBIO
10 hedge funds and large institutions have $767K invested in iBio in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.
119% more capital invested
Capital invested by funds: $349K → $767K (+$417K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$155K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$29.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$5.34K |
| 5 |
Citigroup
New York
|
+$2.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $490K | +$155K | +58 | +47% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $76K | – | – | – |
|
3
Dimensional Fund Advisors
Austin,
Texas
| $68K | – | – | – |
|
|
4
Citadel Advisors
Miami,
Florida
| $56K | +$24K | +9 | +75% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $36K | +$29.4K | +11 | +367% |
|
|
6
Northern Trust
Chicago,
Illinois
| $20K | +$5.34K | +2 | +33% |
|
7
State Street
Boston,
Massachusetts
| $7K | – | – | – |
|
|
U
8
UBS
Zurich,
Switzerland
| $6K | +$2.67K | +1 | +100% |
|
9
Morgan Stanley
New York
| $5K | – | – | – |
|
|
10
Citigroup
New York
| $2K | +$2.67K | +1 | New |
|
11
BNP Paribas Financial Markets
Paris,
France
| $538 | – | – | – |
|
|
PCM
12
Perkins Capital Management
Wayzata,
Minnesota
| – | -$10K | -6 | Closed |
|
IBIO Hedge Fund Activity: Q1 2014 in Review
10 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2014, worth a combined $767K — up 119% from $349K a quarter earlier.
Fund positioning in IBIO was balanced in Q1 2014: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $155K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $10K sold.
- 10 institutional investors held iBio (IBIO) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $767K of iBio stock for Q1 2014, up 119% quarter-over-quarter.
- 1 fund opened new iBio positions in Q1 2014 and 1 closed out, a net change of 0 holders.
- The largest iBio buyer in Q1 2014 was Vanguard Group, an estimated $155K added.
- The largest iBio seller in Q1 2014 was Perkins Capital Management, an estimated $10K sold.
Based on aggregated 13F filings for Q1 2014.